SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr. Reddy's Laboratories informs about allotment of equity shares

02 Jun 2017 Evaluate

Dr. Reddy's Laboratories has informed that the Nomination, Governance & Compensation committee of the Board of Directors of the Company has allotted 46,634 equity shares of Rs 5 each of the Company, fully paid up, on June 1, 2017, to Employees on exercise of their Stock Options as per 45,074 equity shares of Rs. 5 each pursuant to Dr. Reddys Employees Stock Option Scheme, 2002; 1,560 equity shares of Rs 5 each underlying 1,560 ADRs pursuant to Dr. Reddys Employees ADR Stock Option Scheme, 2007. Further, the Company has informed about the details as required under Regulation 10(c) of SEBI (Share Based Employee Benefits) Regulation, 2014.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1293.25 -13.55 (-1.04%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×